BSG and neoplasm: EMMPRIN can induce the expression and activity of the potent pro-angiogenic factor VEGF in tumor cells, fibroblasts, and monocytes by activating the PI3K/Akt pathway [40,41], and to increase the soluble isoforms of VEGF in endothelial cells [42].